Literature DB >> 25644010

Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

Job Alves de Souza Filho1, Vicente de Paulo Martins2, Priscila Carneiro Campos1, Juliana Alves-Silva1, Nathalia V Santos1, Fernanda Souza de Oliveira3, Gustavo B Menezes4, Vasco Azevedo5, Silvio Lorenzo Cravero6, Sergio Costa Oliveira7.   

Abstract

Brucella species can cause brucellosis, a zoonotic disease that causes serious livestock economic losses and represents a public health threat. The mechanism of virulence of Brucella spp. is not yet fully understood. Therefore, it is crucial to identify new molecules that serve as virulence factors to better understand this host-pathogen interplay. Here, we evaluated the role of the Brucella membrane fusogenic protein (Mfp) and outer membrane protein 19 (Omp19) in bacterial pathogenesis. In this study, we showed that B. abortus Δmfp::kan and Δomp19::kan deletion mutant strains have reduced persistence in vivo in C57BL/6 and interferon regulatory factor 1 (IRF-1) knockout (KO) mice. Additionally, 24 h after macrophage infection with a Δmfp::kan or Δomp19::kan strain expressing green fluorescent protein (GFP) approximately 80% or 65% of Brucella-containing vacuoles (BCVs) retained the late endosomal/lysosomal marker LAMP-1, respectively, whereas around 60% of BCVs containing wild-type S2308 were found in LAMP-1-negative compartments. B. abortus Δomp19::kan was attenuated in vivo but had a residual virulence in C57BL/6 and IRF-1 KO mice, whereas the Δmfp::kan strain had a lower virulence in these same mouse models. Furthermore, Δmfp::kan and Δomp19::kan strains were used as live vaccines. Challenge experiments revealed that in C57BL/6 and IRF-1 KO mice, the Δmfp::kan strain induced greater protection than the vaccine RB51 and protection similar that of vaccine S19. However, a Δomp19::kan strain induced protection similar to that of RB51. Thus, these results demonstrate that Brucella Mfp and Omp19 are critical for full bacterial virulence and that the Δmfp::kan mutant may serve as a potential vaccine candidate in future studies.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25644010      PMCID: PMC4363440          DOI: 10.1128/IAI.02790-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Internal affairs: investigating the Brucella intracellular lifestyle.

Authors:  Kristine von Bargen; Jean-Pierre Gorvel; Suzana P Salcedo
Journal:  FEMS Microbiol Rev       Date:  2012-03-22       Impact factor: 16.408

Review 2.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

3.  Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene.

Authors:  Sophie Leclerq; Jerome S Harms; Gracia M S Rosinha; Vasco Azevedo; Sergio C Oliveira
Journal:  J Med Microbiol       Date:  2002-01       Impact factor: 2.472

4.  Economic evaluation of bovine brucellosis and tuberculosis eradication programmes in a mountain area of Spain.

Authors:  A Bernués; E Manrique; M T Maza
Journal:  Prev Vet Med       Date:  1997-05       Impact factor: 2.670

Review 5.  Brucellosis vaccines: past, present and future.

Authors:  Gerhardt G Schurig; Nammalwar Sriranganathan; Michael J Corbel
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

6.  Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice.

Authors:  Thaís Lourdes Santos Lacerda; Patrícia Gomes Cardoso; Leonardo Augusto de Almeida; Ilana Lopes Baratella da Cunha Camargo; Daniela Almeida Freitas Afonso; Cyntia Cardoso Trant; Gilson Costa Macedo; Eleonora Campos; Silvio L Cravero; Suzana P Salcedo; Jean-Pierre Gorvel; Sérgio Costa Oliveira
Journal:  Vaccine       Date:  2010-06-19       Impact factor: 3.641

7.  Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

Authors:  E A Murphy; J Sathiyaseelan; M A Parent; B Zou; C L Baldwin
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

8.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

Review 9.  Brucellosis: a worldwide zoonosis.

Authors:  M L Boschiroli; V Foulongne; D O'Callaghan
Journal:  Curr Opin Microbiol       Date:  2001-02       Impact factor: 7.934

10.  Selective humoral immune response of Balb/C mice to Brucella abortus proteins expressed by vaccinia virus recombinants.

Authors:  T E Toth; J A Cobb; S M Boyle; R M Roop; G G Schurig
Journal:  Vet Microbiol       Date:  1995-07       Impact factor: 3.293

View more
  6 in total

Review 1.  Space: A Final Frontier for Vacuolar Pathogens.

Authors:  Elizabeth Di Russo Case; Judith A Smith; Thomas A Ficht; James E Samuel; Paul de Figueiredo
Journal:  Traffic       Date:  2016-02-24       Impact factor: 6.215

2.  Meta-Analysis and Advancement of Brucellosis Vaccinology.

Authors:  Tatiane F Carvalho; João Paulo A Haddad; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

3.  Modulation of Microtubule Dynamics Affects Brucella abortus Intracellular Survival, Pathogen-Containing Vacuole Maturation, and Pro-inflammatory Cytokine Production in Infected Macrophages.

Authors:  Juliana Alves-Silva; Isabela P Tavares; Erika S Guimarães; Miriam M Costa Franco; Barbara C Figueiredo; João T Marques; Gary Splitter; Sergio C Oliveira
Journal:  Front Microbiol       Date:  2017-11-14       Impact factor: 5.640

4.  Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System.

Authors:  Karina A Pasquevich; Marianela V Carabajal; Francisco F Guaimas; Laura Bruno; Mara S Roset; Lorena M Coria; Diego A Rey Serrantes; Diego J Comerci; Juliana Cassataro
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

Review 5.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

6.  Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response.

Authors:  Mahdieh Sarmadi; Azam Gheibi; Hossein Khanahmad; Mohammad Reza Khorramizadeh; Seyed Hossein Hejazi; Noushin Zahedi; Hamidreza Mianesaz; Khosrow Kashfi
Journal:  Vaccines (Basel)       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.